WATCH: How Serum Institute of India is pricing Covishield

Vaccination against COVID-19 will undergo major modifications next month. Here’s a quick glance.

Why the US and its allies are stupid to turn COVID-19 vaccination into a geopolitical power play

The COVID-19 pandemic demands that all nations cooperate to vaccinate the entire global population—a goal that can’t be achieved …

COVID-19: Why vaccinating those aged 18-44 is an uphill task for Bihar

The state has less than 1% of the required number of vaccine doses 

COVID-19 vaccines: India needs to rise

India has to work hard to defend its position as the global hub of vaccine production

Delta variant of COVID-19 can infect vaccinated people finds AIIMS study

COVID-19: Can India vaccinate all adults in 4 months?

Confronting head-on the vexed pricing of COVID -19 vaccines

It would cost anything between Rs 13,821 crore to Rs 1,10,568 crore to vaccinate the 20-44 age population

What are India’s options for a booster dose of COVID-19 vaccine

Hyderabad-based Biological E’s Corbevax and SII’s Covovax, both of which are protein-based vaccines, are India’s best bet for a …

Coronavirus update: Covaxin works against ‘double mutant’, claims ICMR

Covishield to cost Rs 600 a jab at private hospitals

Tika Utsav and Vaccine Maitri: Finding the right balance

67% medicines produced in India are exported to developing countries

Lateral thoughts: COVID-19 vaccines and a game of chance

Would you be compensated for adverse reactions to the COVID-19 vaccines?  

Hesitancy, logistical challenges behind low turnout at vaccination camps in West Bengal

State is vaccinating health workers beyond the online list generated by Co-WIN app to attain target

India starts COVID-19 vaccination drive; Modi calls doubts over vaccine ‘propaganda’

Prime Minsiter urges people to not drop caution even after being vaccinated 

COVID-19 vaccines: Did a delayed second dose give the delta variant an evolutionary helping hand?

Those with a single dose of the Pfizer or AstraZeneca vaccine less-protected than those with 2 doses: Public Health England

A new study says COVID-19 vaccination is not associated with a heart attack risk

About 1,002 patients who experienced a heart attack had been vaccinated with Covishield and the rest of the 84 with Covaxin

COVID-19: Activists slam Centre’s affidavit washing hands off compensation for vaccine mortality

There was a huge lack of transparency about vaccine-related complications in the government’s awareness campaigns, activists said

No mixing of vaccines in India for booster dose. What do experts say?

Studies point to better protection with mixed doses; experts call data ‘fragmentary’

Omicron threat: How fast is India vaccinating against COVID-19

Rate too slow to meet target of vaccinating every eligible by end of year. The question is: Can Omicron further derail India’s fight …

Resurgence of COVID-19 cases serious concern: Centre

‘Clinical trial mode’ condition of Covaxin manufactured by Bharat Biotech International taken off; Covaxin granted licence similar to …

Bhopal Covaxin trial participants allege side-effects, irregularities

Bhopal-based rights group writes to PM and Union health minister, demanding that ongoing Covaxin trial be halted there

Free COVID-19 vaccines in India from June 21: Everything you need to know

The Centre will buy 75% of total vaccine production and give it to states free of cost

Covid-19 vaccination drive rolled out in Punjab and Himachal Pradesh, skepticism lingers

Some ASHA workers refused to get the jab on Saturday 

Omicron variant: How should India deal with a fresh surge in COVID-19 cases?

India reported 1,700 omicron cases as of January 3

COVID-19 vaccine: After doses, states struggle to get syringes

Manufacturers foresaw demand boom, asked Centre to draw up plan in 2020 itself

Covishield, Covaxin may work against ‘double mutant’

ICMR, CCMB assurance can be a boon amid rising prevalence of B.1.617